Meuser on Covid-19 Testing Availability

Statement

Date: Jan. 6, 2022
Location: Washington, DC

Today, Congressman Dan Meuser (PA-09) released the following statement on the shortage of COVID-19 tests.

"Across Pennsylvania and throughout the country, Americans are unable to find COVID-19 tests in stores and they are waiting in long lines at testing clinics. COVID-19 testing availability has been inadequate since the early summer and demand for tests has been increased since October, yet the Biden administration failed to proactively increase testing capacity, and their response to increased demand in recent weeks has been slow and inadequate. My office continues to work with local healthcare providers, local governments, and the relevant agencies such as Health and Human Services, FEMA, the Pennsylvania Department of Health, and the White House to ensure Pennsylvania has the resources it needs during this surge in cases."

"Although the Biden Administration has promised to invest in rapid testing, send test kits to Americans' homes, and to setup federal testing sites, these initiatives have yet to materialize for most Americans. In fact, these initiatives are too little, too late. In March, President Biden and Congressional Democrats forced through their $1.9 trillion so-called Rescue Plan, less than 10% of which was directed at combatting the public health emergency with vaccines, testing, and therapeutics. At the same time, the Biden Administration diverted $2 billion in funding meant for the Strategic National Stockpile and COVID-19 tests to flights for illegal immigrants, like those that recently landed in Wilkes-Barre. This is an outrageous decision for a President to make in the midst of a pandemic and its consequences are being felt now amid this testing shortage."-Congressman Dan Meuserhealt


Source
arrow_upward